An observational study in Head and Neck Cancer and Esophageal Cancer Stage, sponsored by Yanqing Li. Status unknown at 1 site in China. Per ClinicalTrials.gov, last updated 2018-03-01.
Sponsored by Yanqing Li · Observational
To summarise the outcomes of a treatment decision of patients with superficial esophageal carcinoma synchronously associated with head and neck cancer, that is endoscopic treatment for the superficial esophageal carcinoma plus surgery of the head and neck carcinoma.
As a same risk factor, such as heavy drinking and smoking, patients with head and ncek carcinoma are always suffering from synchronous esophageal squamous cell carcinoma. Previous studies illustrated that many patients with multiple esophageal lesions of early stage. In clinical practice, those patients are treated by extensive surgical resection of total pharyngo-laryngo-esophagectomy plus free jejunum interposition or gastric tube, then followed by chemoradiotherapy as standard treatment, resulting in a low quality of life for the patients, and due to the above mentioned disadvantages, many patients with synchronous superficial esophageal squamous cell carcinoma and head and neck carcinoma refused the surgery treatment. Our aims is to summarize the the outcomes of endoscopic treatment for the superficial esophageal carcinoma plus surgery of head and neck carcinoma.
Patients with head and ncek carcinoma and synchronous superficial esophageal squamous cell carcinoma.
Exclusion Criteria:
The first day of food intake of enrolled patients
The first day of food intake after surgery of the head and neck carcinoma
Time frame: An average of 1week
The relapse rate of the enrolled patients
the relapse rate of esophageal cancer or head and neck carcinoma respectively of the enrolled patients.
Time frame: an average of 2 years
The hospital stay of enrolled patients
The total hospital stay during the first hospitalization of the enrolled patients
Time frame: An average of 1 month.
The incidence of stenosis
The average interval of the stenosis
Time frame: an average of 2 years
The severity of stenosis
The average diameter of the stenosis
Time frame: an average of 2 years
Plan to share: Yes — all the clinical features of the patient are available to all the researchers
Supporting information: Study protocol, Sap, Icf, Csr, Analytic code
No publications or documents are linked to this record.
This study is status unknown, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Yanqing Li